Bicycle Therapeutics (BCYC) Payables (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Payables data on file, last reported at $5.7 million in Q2 2026.

• Quarterly Payables fell 69.0% year-over-year to $5.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.7 million (down 69.0% YoY) and the FY2025 annual result came in at $9.7 million, down 38.78% from the prior year.
• Payables eased to $5.7 million in Q2 2026, from $6.0 million in the prior quarter.
• In the past five years, Payables ranged from a high of $18.3 million in Q2 2025 to a low of $2.8 million in Q1 2023.
• A 5-year average of $8.4 million and a median of $7.1 million in 2022 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables soared 301.51% — and 2026, when it sank 69.0%.
• Tracing BCYC's Payables over 5 years: stood at $6.5 million in 2022, then surged by 101.64% to $13.0 million in 2023, then climbed by 21.02% to $15.8 million in 2024, then plunged by 38.78% to $9.7 million in 2025, then slumped by 41.44% to $5.7 million in 2026.
• The last three Payables figures came in at $5.7 million (Q2 2026), $6.0 million (Q1 2026), and $9.7 million (Q4 2025), per Business Quant data.